Enhanced procoagulant activity of mononuclear leukocytes in patients with atopic dermatitis and psoriasis

R E Schopf1, H Weber, B Morsches

  • 1Universität-Hautklinik, Mainz, Germany.

Insights

Mononuclear leucocytes (MNL) from patients with atopic dermatitis and psoriasis show increased procoagulant activity (PCA), a key factor in skin inflammation. This enhanced PCA in psoriasis correlates with disease activity and normalizes with treatment.

Area of Science:

  • Dermatology
  • Immunology
  • Hematology

Background:

  • Fibrin deposition is a key feature in inflammatory skin conditions.
  • Mononuclear leucocytes (MNL) contribute to fibrin deposition via procoagulant factors.

Purpose of the Study:

  • To investigate if MNL from patients with atopic dermatitis and psoriasis exhibit enhanced procoagulant activity (PCA).

Main Methods:

  • Peripheral blood MNL were isolated from healthy controls, atopic dermatitis patients, and psoriasis patients.
  • MNL were cultured with or without lipopolysaccharide (LPS) for 24 hours.
  • Procoagulant activity was assessed by measuring clotting time in human plasma.

Main Results:

  • MNL from both atopic dermatitis and psoriasis patients demonstrated significantly enhanced PCA, irrespective of LPS stimulation.
  • Supernatants from psoriasis MNL cultures showed augmented PCA, unlike those from atopic dermatitis.
  • In psoriasis, PCA levels decreased to normal following topical anthralin treatment.

Conclusions:

  • Elevated PCA in MNL is a characteristic finding in both atopic dermatitis and psoriasis.
  • In psoriasis, enhanced PCA is directly linked to disease severity and activity.